tiprankstipranks
Advertisement
Advertisement

SGMT Stock Latest News

Sagimet Biosciences Announces Board Changes and Director Elections
Company AnnouncementsSagimet Biosciences Announces Board Changes and Director Elections
2d ago
8K
SGMT
Sagimet Biosciences Grants New Performance-Based Executive Equity Awards
PremiumCompany Announcements
Sagimet Biosciences Grants New Performance-Based Executive Equity Awards
11d ago
8K
SGMT
Sagimet Biosciences price target lowered to $12 from $35 at Citizens
PremiumThe Fly
Sagimet Biosciences price target lowered to $12 from $35 at Citizens
26d ago
SGMT
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
27d ago
DE
HD
SGMT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SGMT Upcoming Earnings Report: What to Expect?
27d ago
SGMT
Sagimet Biosciences price target lowered to $28 from $37 at Clear Street
PremiumThe FlySagimet Biosciences price target lowered to $28 from $37 at Clear Street
1M ago
SGMT
Sagimet Maintained at Buy as Strong Cash Runway and Advancing Acne Franchise Support Unchanged $28 Price Target
Premium
Ratings
Sagimet Maintained at Buy as Strong Cash Runway and Advancing Acne Franchise Support Unchanged $28 Price Target
1M ago
SGMT
Sagimet Biosciences reports Q1 EPS (33c), consensus (35c)
Premium
The Fly
Sagimet Biosciences reports Q1 EPS (33c), consensus (35c)
1M ago
SGMT
Sagimet Biosciences price target raised to $49 from $28 at Canaccord
PremiumThe Fly
Sagimet Biosciences price target raised to $49 from $28 at Canaccord
1M ago
SGMT
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
PremiumThe Fly
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
1M ago
SGMT
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
PremiumRatings
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
1M ago
SGMT
Sagimet Biosciences management to meet virtually with Clear Street
PremiumThe Fly
Sagimet Biosciences management to meet virtually with Clear Street
1M ago
SGMT
Sagimet Biosciences price target lowered to $25 from $27 at Guggenheim
PremiumThe FlySagimet Biosciences price target lowered to $25 from $27 at Guggenheim
2M ago
SGMT
3 Penny Stocks to Watch Now, 4/28/26
Premium
Market News
3 Penny Stocks to Watch Now, 4/28/26
2M ago
HTCO
SGMT
Sagimet Biosciences holds a conference call
Premium
The Fly
Sagimet Biosciences holds a conference call
2M ago
SGMT
TD Cowen establishes $21 price target for Sagamet Bioscinces
PremiumThe Fly
TD Cowen establishes $21 price target for Sagamet Bioscinces
2M ago
SGMT
Sagimet Biosciences Announces Major Equity Offering for Pipeline
PremiumCompany Announcements
Sagimet Biosciences Announces Major Equity Offering for Pipeline
2M ago
8K
SGMT
Sagimet Updates Investor Presentation After Key Clinical Milestones
PremiumCompany Announcements
Sagimet Updates Investor Presentation After Key Clinical Milestones
2M ago
8K
SGMT
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
PremiumCompany Announcements
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
2M ago
8K
SGMT
Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
PremiumCompany AnnouncementsSagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
2M ago
8K
SGMT
Sagimet Biosciences appoints Grauer as Chief Medical Officer
Premium
The Fly
Sagimet Biosciences appoints Grauer as Chief Medical Officer
2M ago
OMER
SGMT
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
3M ago
SGMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >